Detalhe da pesquisa
1.
Clinical presentation and outcomes in patients with antiphospholipid syndrome-associated adrenal hemorrhage. A multicenter cohort study and systematic literature review.
Clin Immunol
; 260: 109906, 2024 03.
Artigo
Inglês
| MEDLINE | ID: mdl-38244823
2.
Multimorbidity in Psoriasis as a Risk Factor for Psoriatic Arthritis: A Population-Based Study.
Rheumatology (Oxford)
; 2024 Jan 30.
Artigo
Inglês
| MEDLINE | ID: mdl-38291896
3.
Clinical features, risk factors, and outcomes of diffuse alveolar hemorrhage in antiphospholipid syndrome: A mixed-method approach combining a multicenter cohort with a systematic literature review.
Clin Immunol
; 256: 109775, 2023 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37722463
4.
2023 ACR/EULAR antiphospholipid syndrome classification criteria.
Ann Rheum Dis
; 82(10): 1258-1270, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37640450
5.
Unpublished clinical trials of common rheumatic diseases.
Rheumatology (Oxford)
; 62(12): 3811-3818, 2023 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36971599
6.
Disparities in multimorbidity and comorbidities in rheumatoid arthritis by sex acrossthe lifespan.
Rheumatology (Oxford)
; 2023 Aug 31.
Artigo
Inglês
| MEDLINE | ID: mdl-37651451
7.
Multimorbidity in systemic lupus erythematosus in a population-based cohort: the lupus Midwest network.
Rheumatology (Oxford)
; 2023 Nov 24.
Artigo
Inglês
| MEDLINE | ID: mdl-38001025
8.
Long-Term Opioid Therapy Among Patients With Systemic Lupus Erythematosus in the Community: A Lupus Midwest Network (LUMEN) Study.
J Rheumatol
; 50(4): 504-511, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36379579
9.
Health Care Utilization in Systemic Lupus Erythematosus in the Community: The Lupus Midwest Network.
J Clin Rheumatol
; 29(1): 29-35, 2023 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36251449
10.
Baricitinib for relapsing giant cell arteritis: a prospective open-label 52-week pilot study.
Ann Rheum Dis
; 81(6): 861-867, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35190385
11.
Rising incidence and prevalence of systemic lupus erythematosus: a population-based study over four decades.
Ann Rheum Dis
; 2022 May 16.
Artigo
Inglês
| MEDLINE | ID: mdl-35577385
12.
Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance.
Ann Rheum Dis
; 81(7): 970-978, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35172961
13.
Population-based incidence and time to classification of systemic lupus erythematosus by three different classification criteria: a Lupus Midwest Network (LUMEN) study.
Rheumatology (Oxford)
; 61(6): 2424-2431, 2022 05 30.
Artigo
Inglês
| MEDLINE | ID: mdl-34718442
14.
Soluble LILRA3 is aberrantly expressed in antiphospholipid syndrome (APS) and is a potential marker of thrombotic APS.
Rheumatology (Oxford)
; 61(12): 4962-4974, 2022 11 28.
Artigo
Inglês
| MEDLINE | ID: mdl-35325077
15.
Risk of hydroxychloroquine retinopathy in the community.
Rheumatology (Oxford)
; 61(8): 3172-3179, 2022 08 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34788400
16.
Epidemiology of Antiphospholipid Syndrome in the General Population.
Curr Rheumatol Rep
; 23(12): 85, 2022 01 05.
Artigo
Inglês
| MEDLINE | ID: mdl-34985614
17.
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry.
Ann Rheum Dis
; 80(9): 1137-1146, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34049860
18.
Treatment of thrombotic antiphospholipid syndrome in adults and children.
Curr Opin Rheumatol
; 32(3): 215-227, 2020 05.
Artigo
Inglês
| MEDLINE | ID: mdl-32187042
19.
16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends.
Lupus
; 29(12): 1571-1593, 2020 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-33100166
20.
Characteristics of Hydroxychloroquine Dispensing in the United States, January to May 2020.
J Gen Intern Med
; 37(1): 176-178, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34704209